The risk of developing and surviving cancer are shaped by where you live, according to a new report. The report, written by The Swedish Institute for Health Economics (IHE) and commissioned by the EFPIA Oncology Platform, finds deep inequalities in access to prevention and screening, biomarker testing and innovative treatments, and in quality of life for cancer survivors.
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.